Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Inhibiting amylolytic enzymes by both acarbose and cellobiose as a prelude to treating type II diabetes mellitus
Dissertation (MSc (Biochemistry))--University of Pretoria, 2024.
Saved in:
| Other Authors: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
University of Pretoria
2024
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867613657345556480 |
|---|---|
| access_status_str | Open Access |
| author2 | Malgas, Malgas |
| author_browse | Malgas, Malgas |
| author_facet | Malgas, Malgas |
| collection | Thesis |
| dc_rights_str_mv | © 2023 University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria. |
| description | Dissertation (MSc (Biochemistry))--University of Pretoria, 2024. |
| format | Thesis |
| id | oai:repository.up.ac.za:2263/94640 |
| institution | University of Pretoria (South Africa) |
| language | English |
| last_indexed | 2026-06-10T12:39:37.287Z |
| license_str | Other — see source repository |
| provenance_str_mv | Harvested via OAI-PMH from UPSpace — University of Pretoria Institutional Repository |
| publishDate | 2024 |
| publishDateRange | 2024 |
| publishDateSort | 2024 |
| publisher | University of Pretoria |
| publisherStr | University of Pretoria |
| record_format | dspace |
| source_str | UPSpace — University of Pretoria Institutional Repository |
| spelling | oai:repository.up.ac.za:2263/94640 Inhibiting amylolytic enzymes by both acarbose and cellobiose as a prelude to treating type II diabetes mellitus Malgas, Malgas Malgas, Samkelo u18200941@tuks.co.za Maluleke, Kamogelo C UCTD Acarbose Combination Therapy Cellobiose Type ll diabetes Synergism Sustainable Development Goals (SDGs) SDG-03: Good health and well-being Natural and agricultural sciences theses SDG-03 Dissertation (MSc (Biochemistry))--University of Pretoria, 2024. Inhibition of starch-degrading enzymes, α-amylase and α-glucosidase, provides a measure to ameliorate type II diabetes mellitus (T2D) by limiting the amount of glucose produced from dietary starch that would subsequently be absorbed into the bloodstream. This study investigated the inhibitory potential of cellobiose in amylolytic enzymes alone and also assessed its synergistic effects when combined with the gold AGI standard, acarbose. Firstly, the pharmacokinetic properties prediction and gastrointestinal digestibility simulation of cellobiose were investigated. Following, in silico molecular docking, in vitro enzyme inhibition, and UV spectroscopy were then used to investigate the inhibitory potential of cellobiose. Lastly, single and combined acarbose and cellobiose were investigated for their inhibition of the amylolytic enzyme cocktail. Cellobiose showed drug-likeness properties and did not possess any toxicity. In addition, it was found to remain stable under gastrointestinal simulated conditions. Acarbose (-7.3 kcal/mol and -8.2 kcal/mol) had the highest binding affinity than cellobiose (-6.0 kcal/mol and -7.5 kcal/mol) for both α-amylase and α-glucosidase, respectively. Upon binding of the compounds to the targets in vitro, acarbose (Ki = 0.012 mM) is a reversible uncompetitive inhibitor, while cellobiose (Ki = 2.2 mM) is a reversible non-competitive inhibitor of α-amylase. On the other hand, both acarbose (Ki = 0.08 mM) and cellobiose (Ki = 14 mM) are reversible competitive inhibitors of α-glucosidase. A combination of acarbose and cellobiose in different ratios resulted in more synergistic results than antagonistic or additive effects, with a 0.005: 1.25 mM (acarbose: cellobiose) being the best combination. The results of the study showed that although cellobiose is not a better inhibitor of amylolytic enzymes, its combination with acarbose leads to synergism which may reduce side effects presented by the gold AGI standard and, as a result, both have the potential to be used for T2D treatment. National Research Foundation (NRF), South Africa. Biochemistry MSc (Biochemistry) Unrestricted Faculty of Natural and Agricultural Sciences 2024-02-15T09:30:36Z 2024-02-15T09:30:36Z 2024-04 2024-02-14 Dissertation * A2024 http://hdl.handle.net/2263/94640 10.25403/UPresearchdata.25219913 en © 2023 University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria. application/pdf University of Pretoria |
| spellingShingle | UCTD Acarbose Combination Therapy Cellobiose Type ll diabetes Synergism Sustainable Development Goals (SDGs) SDG-03: Good health and well-being Natural and agricultural sciences theses SDG-03 Inhibiting amylolytic enzymes by both acarbose and cellobiose as a prelude to treating type II diabetes mellitus |
| title | Inhibiting amylolytic enzymes by both acarbose and cellobiose as a prelude to treating type II diabetes mellitus |
| title_full | Inhibiting amylolytic enzymes by both acarbose and cellobiose as a prelude to treating type II diabetes mellitus |
| title_fullStr | Inhibiting amylolytic enzymes by both acarbose and cellobiose as a prelude to treating type II diabetes mellitus |
| title_full_unstemmed | Inhibiting amylolytic enzymes by both acarbose and cellobiose as a prelude to treating type II diabetes mellitus |
| title_short | Inhibiting amylolytic enzymes by both acarbose and cellobiose as a prelude to treating type II diabetes mellitus |
| title_sort | inhibiting amylolytic enzymes by both acarbose and cellobiose as a prelude to treating type ii diabetes mellitus |
| topic | UCTD Acarbose Combination Therapy Cellobiose Type ll diabetes Synergism Sustainable Development Goals (SDGs) SDG-03: Good health and well-being Natural and agricultural sciences theses SDG-03 |
| url | http://hdl.handle.net/2263/94640 |